Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23817)

Formulation Name
Methylnaltrexone Bromide 150mg tablet
Company
Salix Pharms
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Methylnaltrexone bromide DMZTGN2 Opioid-induced constipation DB32.1 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carmellose sodium E00625 Not Available Disintegrant
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Crospovidone E00626 Not Available Disintegrant
Edetate calcium disodium E00487 6093170 Complexing agent
Hydrophobic colloidal silica E00285 24261 Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Poloxamer 407 E00646 Not Available Emulsifying agent; Solubilizing agent; Surfactant
Polyethylene glycol 4000 E00654 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol E00666 Not Available Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Stearic acid E00079 5281 Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent